A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
CA 2506820 A1 · Owner: Tripep Ab · Inventors: Sallberg, Matti
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Aspects of the present invention relate to the creation of a codon-optimized hepatitis C virus (HCV) NS3/4A gene. Embodiments include said NS3/4A gene fragments of said gene, HCV peptides encoded by said nucleic acids nucleic , acids encoding said HCV peptides antibodies directed to said peptides, compositions containing said nucleic acids and peptides as well as methods of , making and using the aforementioned compositions including but not limited , to, diagnostics and medicaments for the treatment and prevention of HCV infection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 25, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 25, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 25, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.